A Phase 1 Study of IPI-926 in Patients With Advanced and/or Metastatic Solid Tumor Malignancies
Clinical trial NCT00761696 · COMPLETED
Trial details
- NCT number
- NCT00761696
- Sponsor
- Infinity Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2012-04-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.